• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
KZA
Click for more information
8.87% $1.34

KAZIA THERAPEUTICS LIMITED

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
KZA
Brain Cancer Drug Presentation 		27/03/19 18 5.1K
27/03/19 Last post  harvett Comments Created with Sketch.  18  Views Created with Sketch.  5.1K 
KZA
Phase II b 		27/03/19 24 4.7K
27/03/19 Last post  tinhat Comments Created with Sketch.  24  Views Created with Sketch.  4.7K 
KZA
Kazia to Present Cantrixil Data 		26/03/19 1 396
26/03/19 Last post  GCInvestor Comments Created with Sketch.  1  Views Created with Sketch.  396 
KZA
Ann: Kazia sells stake in Noxopharm 		21/03/19 28 57K
21/03/19 Last post  stockboy999 Comments Created with Sketch.  28  Views Created with Sketch.  57K 
KZA
News: KZA Kazia Therapeutics To Sell Remainder Of Holdings In Noxopharm 		19/03/19 1 6.6K
19/03/19 Last post  stockboy999 Comments Created with Sketch.  1  Views Created with Sketch.  6.6K 
KZA
Ann: Appendix 3B placement capacity 		19/03/19 12 40K
19/03/19 Last post  stockboy999 Comments Created with Sketch.  12  Views Created with Sketch.  40K 
KZA
SP 		19/03/19 45 16K
19/03/19 Last post  cane Comments Created with Sketch.  45  Views Created with Sketch.  16K 
KZA
Since current chemo doesn't work.. 		13/03/19 4 1.2K
13/03/19 Last post  onesurfed Comments Created with Sketch.  4  Views Created with Sketch.  1.2K 

See All Discussions arrow Created with Sketch.

Top Stories

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
CuFe sells its Crossroads gold royalty to Northern Star for $4M cash; says better than waiting for mine launch CuFe Ltd (ASX:CUF) has decided not to wait around for Northern Star's Crossroads mine to get up and running, selling its $4M royalty right.
NT Gov't delivers environmental approval for Empire Energy's Beetaloo Carpentaria pilot gas play Empire Energy (ASX:EEG) has confirmed the NT government has delivered environmental approvals for Carpentaria.
Blue Star Helium sees approval for five more wells at 'Galactica/Pegasus' project in Colorado Blue Star Helium (ASX:BNL) has won approval from Colorado regulators to drill five fresh helium wells at its flagship.
Banshee's historic trenches prove rich in antimony and gold for GDM Great Divide Mining Ltd has found high-grade antimony and gold through geochemical sampling at its Banshee prospect in Queensland
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.